Researchers have identified specific brain lesions associated with reduced PTSD symptoms in veterans, providing a potential noninvasive neuromodulation target. TMS applied to this PTSD circuit could o...

Background: In the United States and worldwide, chronic pain affects a vast number of people and is one of the leading reasons adults seek medical care. In the United States, 24.3% of adults reported experiencing chronic pain in the prior 3 months in 2023. Chronic pain is defined as pain that lasts ≥3 months, significantly disrupting one’s daily functioning and quality of life. Chronic pain can also be accompanied by other conditions, including anxiety and depression. Health care providers should be aware of several limitations in their current treatment modalities. Although opioid analgesics are used for moderate to severe pain management, they cause many serious adverse effects, including sedation, respiratory depression, constipation, and a high risk of dependence and addiction. Other pain medications, such as nonopioid analgesics, including nonsteroidal anti-inflammatory drugs, adjuvant analgesics, and corticosteroids, also cause a range of side effects and organ toxicity. Objective: We conducted a single-arm exploratory pilot study to explore the potential role of a noninvasive, transdermal, audio-based therapeutic system among 24 police professionals aged 21 to 65 years with chronic pain and/or associated conditions, including migraine, sleep disorders, stress, anxiety, and conventional headaches. Methods: In this STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)–guided pilot study, we explored the #feasibility and perceived effectiveness of a self-administered intervention based on the Transdermal Acoustic Pain Suppression (TAPS) system among police personnel in West Palm Beach, Florida. Participants completed a flexible 30-day protocol integrated into their work schedules, with data collection spanning 5 months due to operational constraints. We used percentages as measures of effect and the chi-square test and Fisher exact test for significance testing. All P values were 2-sided, with a level of significance of .05. Results: In this small pilot study, following TAPS therapy, more than one-third (n=9, 37.5%) of participants experienced improvement in their condition, and half (n=12, 50%) reported reduced symptoms, including notable pain reduction. Conclusions: Although the findings from this small pilot study are preliminary, we believe they support the rationale for larger analytic studies designed a priori to test the hypothesis.

A woman who struggled with severe meth addiction claims that a single session of non-invasive focused ultrasound therapy provided relief that years of traditional treatment could not. The case highlights the potential of advanced medical technologies in treating neurological conditions. The patient, whose identity has not been disclosed, described the experience as transformative, with the treatment targeting specific brain regions associated with addiction. Medical professionals emphasize that while the case is groundbreaking, more research is needed to determine its broader applicability. The incident has sparked discussions about the future of non-invasive brain treatments and their potential to revolutionize addiction care. However, experts caution that such cases should be approached with scientific rigor to avoid overhyping unproven therapies. The story underscores the complex interplay between technological innovation and medical ethics in the field of neurology.

💬 0  🔁 0  ❤️ 0 · Heal Faster with Class IV LASER Therapy | Golden Maple Physiotherapy · ✨ Experience the power of Class IV LASER Therapy at Golden Maple Physiotherapy in Maple Ridge! This advanced…

💬 0  🔁 0  ❤️ 0 · Class IV Laser Therapy | Maple Ridge Physio · LASER Therapy - Class IV Class IV LASER Therapy is an advanced treatment that accelerates healing, reduces pain, and decreases inflam…